by Nisha Cooch, PhD | Oct 30, 2019 | Genetic Counselors News, Neurology News, News, Radiology News, slider
Data on SMA continue to roll out. This month has shown a growing focus and understanding on issues related to nusinersen as well as newborn screening for SMA across the globe. In addition, more preclinical and translation results have been published. Below is the...
by Nisha Cooch, PhD | Oct 10, 2019 | Genetic Counselors News, Neurology News, News, Nursing News, Pediatricians News
The beginning of fall has seen a steady stream of new data elucidating SMA mechanisms, as well as options for managing and treating the disease. There have also been reports of evolving efforts to optimize both SMA research and clinical care, such as through a new SMA...
by Nisha Cooch, PhD | Sep 26, 2019 | Genetic Counselors News, Neurology News, News, Orthopedics News, Pediatricians News, Physical Therapists News
Summer has closed with new data and news on SMA coming to the fore. Much of the research on SMA published in recent weeks has focused on how to best treat the disease, and some new debate has emerged surrounding the relative advantages of Zolgensma versus Spinraza. At...
by Nisha Cooch, PhD | Jun 18, 2019 | Genetic Counselors News, Neurology News, News, Nursing News, Nutritionist News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News, Radiology News, Urologists News
Since our last roundup, there has been continued focus in the spinal muscular atrophy (SMA) literature how best to treat the disease. There also continues to be research geared toward understanding the biology of the disease, as well as on SMA management, what it is...
by Nisha Cooch, PhD | Jun 3, 2019 | Genetic Counselors News, Neurology News, News, Nursing News, Nutritionist News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News, Radiology News, Social Worker News, Urologists News
Much of the most recent research regarding spinal muscular atrophy (SMA) has focused on understanding the mechanisms mediating the disease as well as the clinical value of different pharmaceutical interventions. There have been several reviews on the latter topic,...
by Michael Nace | May 24, 2019 | Genetic Counselors News, Just Published, Neurology News, News, Nursing News, Nutritionist News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News, Radiology News, Social Worker News, Urologists News
Zolgensma, a first gene therapy for spinal muscular atrophy — and first for any chronic neurologic disease — is now an approved and potential “one-time” intravenous treatment for pre-symptomatic newborns through 2-year-olds with any type of SMA, the U.S. Food and Drug...
